Biohaven Pharmaceutical
BHVN
Rank 1917
Country USA
Exchange NYSE
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 215 CHURCH STREET, NEW HAVEN, CT, US
Biohaven Pharmaceutical - Key figures
Market cap 10.02 Billion
Revenue 462.51 Million
Profit 370.85 Million
P/E Ratio No information
P/s Ratio 21.66
Biohaven Pharmaceutical - Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States.
The company is headquartered in New Haven, Connecticut.